CYP2C9 polymorphism: Prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia

Singapore Medical Journal

Volumn 50, Issue 5, 2009, Pages 490-493

  Ngow, Harris A ^a   Wan Khairina, W M N ^b   Teh, L K ^d   Lee, W L ^d   Harun, R ^c   Ismail, R ^e   Salleh, M Z ^d  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^b MINISTRY OF HEALTH   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d University Teknologi ^*  (Malaysia)

^e INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

CYP2C9 frequency; Genetic polymorphism; Pharmacogenomics testing; Warfarin

Indexed keywords

CYTOCHROME P450 2C9; WARFARIN; ANTICOAGULANT AGENT; CYP2C9 PROTEIN, HUMAN; UNSPECIFIC MONOOXYGENASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA ISOLATION; ETHNICITY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL RECORD REVIEW; MULTIPLEX POLYMERASE CHAIN REACTION; PHARMACOGENOMICS; PREVALENCE; ALLELE; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; DRUG MONITORING; ETHNOLOGY; GENETICS; METABOLISM; PHARMACOGENETICS;

ALLELES; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CHINA; DRUG MONITORING; HUMANS; MALAYSIA; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PREVALENCE; WARFARIN; CYTOCHROME P-450 CYP2C9;

EID: 67149098310     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lee CR, Goldstein JA and Pieper JA. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 2002; 12:251-263 (Pubitemid 34596790)
2. Takahashi H, Echizen H. Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharmacokinet 2001; 40:587-603. (Pubitemid 32758581)
3. Takahashi H, Wilkinsin GR, Caraco Y, et al. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clin Pharmacol Ther 2003; 73:253-263 (Pubitemid 36269676)
4. Dorado P, Berecz R, Norbeto MJ, et al. CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers. Eur J Clin Pharmacol 2003; 59:221-225 (Pubitemid 37009744)
5. Odani A, Hashimoto Y, Otsuki Y, et al. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. Clin Pharmacol Ther 1997; 62:287-292 (Pubitemid 27417794)
6. Shon JH, Yoon YR, Kim KA, et al. Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans. Pharmacogenetics 2002; 12:111-119 (Pubitemid 34298915)
7. Aithal GP, Day CP, Kesteven PJL, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999; 353:717-719 (Pubitemid 29103806)
8. García-Martín E, Martínez C, Ladero JM, Gamito FJ, Agúndez JA. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population. Eur J Clin Pharmacol 2001; 57:47-49 (Pubitemid 32391412)
9. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, et al. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur J Clin Pharmacol 2003; 59:303-312 (Pubitemid 37100349)
10. Yasar U, Aklillu E, Canaparo R, et al. Analysis of CYP2C9*5 in Caucasian, Oriental and Black-African populations. Eur J Clin Pharmacol 2002; 58:555-558 (Pubitemid 35435508)
11. Aynacioglu AS, Brockmöller J, Bauer S, et al. Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol 1999; 48:409-415 (Pubitemid 29417726)
12. Imai J, Ieiri I, Mamiya K,et al. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics 2000; 10:85-89
13. Yoon YR, Shon JH, Kim MK, et al. Frequency of cytochrome P450 2C9 mutant alleles in a Korean population. Br J Clin Pharmacol 2001; 51:277-280 (Pubitemid 32396418)
14. Adithan C, Gerard N, Vasu S, et al. Allele and genotype frequency of CYP2C9 in Tamilnadu population. Eur J Clin Pharmacol 2003; 59:707-709 (Pubitemid 37498209)
15. Zainuddin Z, Teh LK, Suhaimi AWM, Salleh MZ, Ismail R. A simple method for the detection of CYP2C9 polymorphisms: nested allele-specific multiplex polymerase chain reaction. Clin Chim Acta 2003; 336:97-102. (Pubitemid 37324759)
16. Ku CS, Gan GG, Sangkar JV, Phipps ME. Frequency of Cytochrome P450 2C9 (CYP2C9) Allelles in Three Ethnic Groups in Malaysia. Asia Pac J Mol Biol Biotechnol 2003; 11:83-91. (Pubitemid 38372171)
17. Zainuddin Z, Teh LK, Suhaimi AW, Ismail R. Malaysian Indians are genetically similar to Caucasians: CYP2C9 polymorphism. J Clin Pharm Ther 2006; 31:187-191
18. Scordo MG, Aklillu E, Yasar U, et al. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br J Clin Pharmacol 2001; 52:447-450 (Pubitemid 32939447)